News and Media

Latest News Release

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...


Press Releases

Cardinal Health Names Daniel J. Walsh to Lead New Ethics and Compliance Post

DUBLIN, Ohio, May 11, 2005 - Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health-care industry, today named Daniel J. Walsh to the new post of executive vice president and chief ethics and compliance officer, reporting to both Robert D. Walter, chairman and chief executive officer, and the audit committee of Cardinal Health's board.

Since 2003, Walsh, 49, has been vice president and chief compliance officer at the Atlanta-based Scientific-Atlanta, Inc., where he was responsible for the creation and oversight of a broad corporate compliance program incorporating best practices in education, policy, hotline administration and compliance monitoring.

"Cardinal Health has longstanding structures in place to promote compliance, but Dan's appointment underlines our commitment to the highest standards of ethics, integrity and compliance," said Walter. "The exemplary work he has done throughout his career will serve as a model for us."

From 1993 to 2003, Walsh was corporate compliance officer serving in the New York, London and Washington, D.C. offices of Smiths Group PLC, a global provider of medical, industrial and aerospace products. From 1986 to 1993, he was a director and senior manager in the management consulting division of PricewaterhouseCoopers' New York and Washington, D.C. offices. Earlier, he held compliance and auditing positions at the Loral Corporation and for the U.S. Department of Defense.

Walsh earned a Master of Business Administration degree in executive management from New York's St. John's University and is licensed in New York as a certified public accountant.

Walsh joins Cardinal Health on May 18. As part of his duties, he will be a member of Cardinal Health's executive committee, disclosure committee and will chair the corporate responsibility committee.

About Cardinal Health
Cardinal Health, Inc. ( is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals, medical- surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000 people on six continents and produces annual revenues of more than $65 billion.

More Company News

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend...


Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS...


Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...


The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

View all company news »